You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 16, October 28, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •eFigures
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Renal Diseases
 •Dialysis
 •Renal Diseases, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICIAN'S CORNER
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis

Dinanda J. de Jager, MSc; Diana C. Grootendorst, PhD; Kitty J. Jager, MD, PhD; Paul C. van Dijk, PhD; Lonneke M. J. Tomas; David Ansell, PhD; Frederic Collart, MD, PhD; Patrik Finne, MD, PhD; James G. Heaf, MD, DMSc; Johan De Meester, MD, PhD; Jack F. M. Wetzels, MD, PhD; Frits R. Rosendaal, MD, PhD; Friedo W. Dekker, PhD

JAMA. 2009;302(16):1782-1789.

Context  Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population.

Objective  To evaluate if high overall mortality in patients starting dialysis is a consequence of increased cardiovascular mortality risk only or whether noncardiovascular mortality is equally increased.

Design, Setting, and Patients  Using data from between January 1, 1994, and January 1, 2007, age-stratified mortality in a European cohort of adults starting dialysis and receiving follow-up for a mean of 1.8 (SD, 1.1) years (European Renal Association–European Dialysis and Transplant Association [ERA-EDTA] Registry [N = 123 407]) was compared with the European general population (Eurostat).

Main Outcome Measures  Cause of death was recorded by ERA-EDTA codes in patients and matching International Statistical Classification of Diseases, 10th Revision codes in the general population. Standardized cardiovascular and noncardiovascular mortality rates, their ratio, difference, and relative excess of cardiovascular over noncardiovascular mortality were calculated.

Results  Overall all-cause mortality rates in patients and the general population were 192 per 1000 person-years (95% confidence interval [CI], 190-193) and 12.055 per 1000 person-years (95% CI, 12.05-12.06), respectively. Cause of death was known for 90% of the patients and 99% of the general population. In patients, 16 654 deaths (39%) were cardiovascular and 21 654 (51%) were noncardiovascular. In the general population, 7 041 747 deaths (40%) were cardiovascular and 10 183 322 (58%) were noncardiovascular. Cardiovascular and noncardiovascular mortality rates in patients were respectively 38.1 per 1000 person-years (95% CI, 37.2-39.0) and 50.1 per 1000 person-years (95% CI, 48.9-51.2) higher than in the general population. On a relative scale, standardized cardiovascular and noncardiovascular mortality were respectively 8.8 (95% CI, 8.6-9.0) and 8.1 (95% CI, 7.9-8.3) times higher than in the general population. The ratio of these rates, ie, relative excess of cardiovascular over noncardiovascular mortality in patients starting dialysis compared with the general population, was 1.09 (95% CI, 1.06-1.12). Relative excess in a sensitivity analysis in which unknown/missing causes of death were regarded either as noncardiovascular or cardiovascular varied between 0.90 (95% CI, 0.88-0.93) and 1.39 (95% CI, 1.35-1.43).

Conclusion  Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality.


Author Affiliations: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands (Drs Grootendorst, Rosendaal, and Dekker and Mss De Jager and Tomas); ERA-EDTA Registry, Academic Medical Center, Department of Medical Informatics, Amsterdam, the Netherlands (Drs Jager and van Dijk); United Kingdom Renal Registry, Bristol (Dr Ansell); French-Speaking Belgium ESRD Registry, Bruxelles (Dr Collart); Finnish Registry for Kidney Disease, Helsinki (Dr Finne); Department of Nephrology, Copenhagen University Hospital at Herlev, Herlev, Denmark (Dr Heaf); Department of Nephrology, Dialysis and Hypertension, AZ Nikolaas, Sint-Niklaas, Belgium (Dr De Meester); and Department of Nephrology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (Dr Wetzels).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mortality in Dialysis Patients
JWatch General 2009;2009:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.